CCR6 and COVID-19: In agreement with our data, De Biasi et al. showed that patients with COVID-19 displayed a lower level of Th17 cells with CCR6+CD4+CD3+ and CCR6+CD161+CD4+CD3+ phenotypes [38], and Gutiérrez-Bautista J. et al. demonstrated a persistently low frequency of markers associated with Th1, Th17, and Th1/Th17 memory-effector T cells compared to healthy donors [39].